Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Vilanterol Impurity 1

Vilanterol Impurity 1 is listed in the pharmaceutical impurity collection under CAS 2014-83-7. Its represented structure has formula C7H5Cl3 and a calculated molecular weight of 195.48 g/mol.

2D chemical structure

C l C l C l

Chemical identity

Catalog name
Vilanterol Impurity 1
Common name
Vilanterol Impurity 1
Chemical name
1,3-dichloro-2-(chloromethyl)benzene
CAS
2014-83-7
SMILES
ClCc1c(Cl)cccc1Cl
InChI
InChI=1S/C7H5Cl3/c8-4-5-6(9)2-1-3-7(5)10/h1-3H,4H2
InChIKey
LBOBESSDSGODDD-UHFFFAOYSA-N
Associated API
Vilanterol

Record ID: Aa5770616d2c1

Computed properties

C7H5Cl3 Molecular formula
195.476 g/molMolecular weight
193.9457 DaMonoisotopic exact mass
0 ŲTopological polar surface area
3.7322 Calculated LogP (Wildman–Crippen)
46.019 cm³/molMolar refractivity (Wildman–Crippen)
0 countHydrogen-bond acceptors
0 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 1 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C Cl H 0 2 4 6 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight195.47616.49
Calculated LogP (Wildman–Crippen)3.732274.52
Topological polar surface area00.50
Hydrogen-bond acceptors00.47
Hydrogen-bond donors011.28
Rotatable bonds (strict)112.12

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC7H5Cl3dimensionless
Molecular weight195.476g/mol
Monoisotopic exact mass193.9457Da
Topological polar surface area0Ų
Calculated LogP (Wildman–Crippen)3.7322dimensionless
Molar refractivity (Wildman–Crippen)46.019cm³/mol
Hydrogen-bond acceptors0count
Hydrogen-bond donors0count
Rotatable bonds (strict)1count
Heavy atoms10count
Heteroatoms3count
Rings1count
Aromatic rings1count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles0count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles1count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.1429fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area74.7061Ų
Valence electrons54count
Radical electrons0count
Bertz complexity212.0429index
Balaban J3.1695index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Vilanterol Impurity 1

Qualification and safety assessment of Vilanterol Impurity 1

Explore toxicological qualification of Vilanterol Impurity 1 and ICH M7 mutagenic impurity assessment of Vilanterol Impurity 1 for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Vilanterol Impurity 1 and acceptable intake and limit justification for Vilanterol Impurity 1. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Vilanterol Impurity 1

Explore Altox services and software through the Altox Pharma-Hub.